0001658367-18-000002.txt : 20180817 0001658367-18-000002.hdr.sgml : 20180817 20180817120102 ACCESSION NUMBER: 0001658367-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180817 DATE AS OF CHANGE: 20180817 EFFECTIVENESS DATE: 20180817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ILIAD BIOTECHNOLOGIES, LLC CENTRAL INDEX KEY: 0001658367 IRS NUMBER: 454419429 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-319516 FILM NUMBER: 181025177 BUSINESS ADDRESS: STREET 1: 230 E 15TH STREET STREET 2: SUITE 1-A CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 917-913-8511 MAIL ADDRESS: STREET 1: 230 E 15TH STREET STREET 2: SUITE 1-A CITY: NEW YORK STATE: NY ZIP: 10003 D 1 primary_doc.xml X0708 D LIVE 0001658367 ILIAD BIOTECHNOLOGIES, LLC 4581 WESTON ROAD SUITE 260 WESTON FL FLORIDA 33331 917-913-8511 DELAWARE None None Limited Liability Company true KEITH RUBIN 4581 WESTON ROAD SUITE 260 WESTON FL FLORIDA 33331 Executive Officer Director KEN SOLOVAY 4581 WESTON ROAD SUITE 260 WESTON FL FLORIDA 33331 Executive Officer CUONG DO 4581 WESTON ROAD SUITE 260 WESTON FL FLORIDA 33331 Director BIN YAN 4581 WESTON ROAD SUITE 260 WESTON FL FLORIDA 33331 Director Biotechnology Decline to Disclose 06b false 2018-07-14 false true true true (1) Class B Units or at holder's option, Class C Units if established prior to the conversion deadline, and (2) Warrants to acquire Class B Units. false 0 WALTER C. GREENBLATT 4723413 WALTER GREENBLATT & ASSOCIATES 129291 430 NASSAU STREET PRINCETON NJ NEW JERSEY 08540 CT CONNECTICUT FL FLORIDA GA GEORGIA NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA false 5000000 550000 4450000 false 2 400000 true 0 Sales compensation equals 8% of the amount invested ($400,000 is estimated based on the assumption that the offering is fully subscribed). 500000 Estimated 10% of proceeds will be used to pay salaries of Ken Solovay and Keith Rubin ($500,000 assumes the offering is fully subscribed). false ILIAD BIOTECHNOLOGIES, LLC KEITH RUBIN KEITH RUBIN CHIEF EXECUTIVE OFFICER 2018-08-17